Gritstone Oncology Inc.

(NASDAQ:GRTS) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Gritstone Oncology Inc is a United States-based biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE-001 and SLATE-001.

Contact Information

Website: www.gritstoneoncology.com
Email: ir@gritstone.com
Main Phone: +1 510 871-6100
Address: 5959 Horton Street
Address 2: Suite 300
State: CA
City / Town: Emeryville
Country: US
Postal Code: 94608

Issuer Information

Exchange: NGS
CEO: Andrew R. Allen
Employees: 169
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A